Automated Agitation Management Accounting for Saturation Dynamics

Agitation-sedation cycling in critically ill is damaging to patient health and increases length of and cost. A physiologically representative model of the agitation-sedation system is used as a platform to evaluate feedback controllers offering improved agitation management. A heavy-derivative controller with upper and infusion rate bounds maintains minimum plasma concentrations through a low constant infusion, and minimizes outbursts of agitation through strong, timely boluses. controller provides improved agitation management using from 37 critically ill patients, given the saturation of effect at high concentration. Approval was obtained the Canterbury Ethics Board for this research.

[1]  Christina Starfinger,et al.  Quantifying agitation in sedated ICU patients using heart rate and blood pressure. , 2004, Physiological measurement.

[2]  Dominic S. Lee,et al.  Modeling and control of the agitation-sedation cycle for critical care patients. , 2004, Medical engineering & physics.

[3]  G. Brattebø,et al.  Effect of a scoring system and protocol for sedation on duration of patients’ need for ventilator support in a surgical intensive care unit* , 2004, Quality & safety in health care.

[4]  G. Guyatt,et al.  Adaptation to the Intensive Care Environment (ATICE): Development and validation of a new sedation assessment instrument , 2003, Critical care medicine.

[5]  G. Wake,et al.  Modelling and control of the agitation-sedation cycle , 2003 .

[6]  R. Boulieu,et al.  Evaluation of the estimation of midazolam concentrations and pharmacokinetic parameters in intensive care patients using a bayesian pharmacokinetic software (PKS) according to sparse sampling approach , 2003, The Journal of pharmacy and pharmacology.

[7]  U. Hofmann,et al.  Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. , 2002, British journal of clinical pharmacology.

[8]  Z-H Lam,et al.  Active insulin infusion using optimal and derivative-weighted control. , 2002, Medical engineering & physics.

[9]  S L Shafer,et al.  Response Surface Model for Anesthetic Drug Interactions , 2000, Anesthesiology.

[10]  J. Kress,et al.  Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. , 2000, The New England journal of medicine.

[11]  H. Schwilden,et al.  The effect of age on the pharmacokinetics and pharmacodynamics of midazolam , 1999, Clinical pharmacology and therapeutics.

[12]  D. O'Hara,et al.  Pharmacokinetics and Pharmacodynamics of Sedatives and Analgesics in the Treatment of Agitated Critically Ill Patients , 1997, Clinical pharmacokinetics.

[13]  R. Fragen Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units. , 1997, Clinical therapeutics.

[14]  A. Donner,et al.  Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. , 1995, Critical care clinics.

[15]  R. Levine Pharmacology of intravenous sedatives and opioids in critically ill patients. , 1994, Critical care clinics.

[16]  L. Smith,et al.  The Pharmacokinetics of Midazolam in Chronic Renal Failure Patients , 1983, Anesthesiology.